Reportlinker Adds Global Top 100 Pharmaceutical Manufacturers Industry Analysis
NEW YORK, Dec. 7, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Top 100 Pharmaceutical Manufacturers Industry Analysis
The Global Top 100 Pharmaceutical Industry Report
This report is an in-depth financial evaluation of the Global Top 100 Pharmaceutical companies. Using the unique Plimsoll method of analysis, each of the Global Top 100 Pharmaceutical Manufacturers is individually assessed and ranked against each other and compared to industry averages. Using the most up-to-date financial information available, the two-page analysis provides detailed financial analysis for each organisation, including details of;
• Sales growth
• Trading stability
• Profitability
• Employee performance
• Level of debt
• Gearing ratio's
• Creditor Exposure
• Performance ratio's
• Overall financial rating
Results are shown in graphical, numeric and narrative forms, and all individual analysis are measured in both the company's own currency, and USD ($) for ease of use. These individual analyses highlight a company's success just as easily as it can emphasise its vulnerability.
Along with individual company information, this report also contains an assessment of the market, based on the companies analysed. This key information identifies;
• Best trading partners (based on commercial and financial strength)
• Sales growth (highest sales, growth rate, size of market based on the companies analysed, average growth)
• Profitability (Profit return on assets, pre-tax profit margins, industry average)
• Fastest growing companies (performance matrix)
Companies can change at an alarming rate in a very short space of time, so it is vital that you keep up-to-date with any changes to your market, and how those changes can affect you. This report can provide you with an in-depth look at your industry, highlight new market opportunities and provide important information to help develop accurate strategic business plans. Whether you wish to benchmark your own company's results, study the industry in more depth or have a vast array of industry intelligence at your disposal, this report is the ideal resource.
This extensive report is broken into two parts:
1. A complete financial assessment of the market, based on the companies analysed
2. An individual financial performance analysis of each company (2 pages per company)
Specific areas included in the market assessment include;
Section 1 - Best Trading Partners (based on commercial and financial strength)
1.1a – Best Trading Partners definition and industry top 5 list
1.1b – Performance matrix (Financial Strength Vs Sales Growth)
1.1c – List of Best Trading Partners in the industry
Section 2 - Sales & Market Performance
2.1 – Sales Growth
2.1a – 4 year trend analysis
2.1b – Industry Average Sales Growth
2.1c – Sales Growth Ranking Table
2.1d – Top 50 Companies ranked by Market Share
2.2 – Sales Return on Assets
2.2a – 4 year trend analysis
2.2b – Sales return on total assets
2.2c – Sales return on assets ranking table
2.2d – Top 50 companies' sales return on assets
Section 3 – Profitability
3.1 – Pre-tax profit margin
3.1a – Pre-tax profit margin 4 year trend analysis
3.1b – Industry Average pre-tax profit margin
3.1c – Pre-tax profit margin ranking table
3.1d – Top 50 companies actual pre-tax profit
3.2 - Pre-tax profit return on total assets
3.2a - Pre-tax profit return on total assets 4 year trend analysis
3.2b – Industry average pre-tax profit return on total assets
3.2c – Pre-tax profit return on total assets ranking table
3.3 - Profitability
3.3a – Profitability industry average
4. 0 – How to Use
5.0 – Individual Company Analysis
The individual company assessment gives a complete financial picture of each company listed, including a narrative summary of the analysis. One of our key indicators is the Plimsoll Chart which combines several performance figures to give an overall measurement of the financial strength of any company. The Plimsoll chart is complied through the analysis of several different areas, including;
Sales Growth, Trading Stability, Profitability, Working Capital, Gearing and Immediate Liquidity
As all measurements are standardised, in one report you can quickly compare like with like for every major company in your industry. The accounts of each company appear in its own currency and US$ to allow comparison.
Each individual company analysis includes:
• A full four year financial assessment, Debtor days analysis, Latest sales/profitability rankings.
• Employee Performance Analysis, Comparisons against industry average.
• Overall company financial rating as read in the Plimsoll Chart, Industry ranking matrix.
• Company analysis written summary.
Other information in the report includes;
• Details of the Plimsoll Model
• Definition of Terms
• List of Shareholders
• Global Index by region
• Ranking Analysis by sales/profits
• Companies considered but not included
• Index of companies
Companies mentioned
JOHNSON & JOHNSON
PFIZER INC
BAYER AG
ROCHE HOLDING AG
NOVARTIS AG
SANOFI-AVENTIS
GLAXOSMITHKLINE PLC
ASTRAZENECA PLC
ABBOTT LABORATORIES
NOVARTIS PHARMA AG
MERCK & CO INC
WYETH
BRISTOL-MYERS SQUIBB COMPANY
ELI LILLY AND COMPANY
SCHERING PLOUGH CORP
BOEHRINGER INGELHEIM GMBH
AMGEN INCORPORATED
TAKEDA PHARMACEUTICAL CO., LTD.
GENENTECH INC
SOLVAY SA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
MERCK KGAA
ASTELLAS PHARMA INC.
DAIICHI SANKYO CO., LTD.
NOVO NORDISK A/S
EISAI CO LTD
OTSUKA PHARMACEUTICAL CO LTD
BAYER SCHERING PHARMA AG
SANKYO CO LTD
GILEAD SCIENCES INC
B BRAUN MELSUNGEN AG
MYLAN INC.
UCB NV/SA
JANSSEN PHARMACEUTICA
GENZYME CORPORATION
ALLERGAN INC
AKZO NOBEL NV
FOREST LABORATORIES INC
KYOWA HAKKO KIRIN CO., LTD.
A. MENARINI - INDUSTRIE FARMACEUTICHE RIUNITE - S.R.L.
HOSPIRA, INC.
CSL LIMITED
CHUGAI PHARMACEUTICAL CO., LTD.
MITSUBISHI TANABE PHARMA CORP.
LES LABORATOIRES SERVIER
GALENICA AG
MERCK SERONO S.A.
DAINIPPON SUMITOMO PHARMA CO., LTD.
WATSON PHARMACEUTICALS INC
BARR PHARMACEUTICALS, INC.
TAISHO PHARMACEUTICAL CO LTD
MERIAL LIMITED
SHIRE PLC
STADA ARZNEIMITTEL AG
CELGENE CORP
MITSUBISHI PHARMA CORPORATION
SANOFI PASTEUR
SHIONOGI & COMPANY LIMITED
H. LUNDBECK A/S
SIGMA PHARMACEUTICALS LIMITED
HEXAL AKTIENGESELLSCHAFT
PERRIGO CO
ACTAVIS GROUP HF
YANGTZE RIVER PHARMACEUTICAL GROUP CO., LTD.
INVERNESS MEDICAL INNOVATIONS, INC.
ALAPIS S.A.
KING PHARMACEUTICALS INC
RANBAXY LABORATORIES LIMITED
NOVOZYMES A/S
ONO PHARMACEUTICAL CO LTD
IPSEN SA
HARBIN PHARMACEUTICAL GROUP CO., LTD.
ACTELION LTD
CSL BEHRING GMBH
KRKA DD NOVO MESTO
SEPRACOR INC
DR REDDY'S LABORATORIES LIMITED
HISAMITSU PHARMACEUTICAL CO, INC.
ENDO PHARMACEUTICALS HOLDINGS INC
RICHTER GEDEON VEGYESZETI GYAR RT
TAIHO PHARMACEUTICAL CO.,LTD.
OCTAPHARMA AG
OMEGA PHARMA NV
CIPLA LTD
LEO PHARMA A/S
ROHTO PHARMACEUTICAL CO LTD
SANTEN PHARMACEUTICAL CO LTD
ORION OYJ
PLIVA D.D.
RECORDATI SPA
TSUMURA & COMPANY
ZENTIVA N.V.
WARNER CHILCOTT LIMITED
CHINA PHARMACEUTICAL GROUP LIMITED
HUADONG MEDICINE CO., LTD.
SUN PHARMACEUTICAL INDUSTRIES LIMITED
AMYLIN PHARMACEUTICALS INC
YUNNAN BAIYAO GROUP CO., LTD.
MAX INDIA LIMITED
ELAN CORPORATION PUBLIC LIMITED COMPANY
BIOVAIL CORPORATION
PATHEON INC
KOS PHARMACEUTICALS INC
To order this report:
Pharmaceutical Industry: Global Top 100 Pharmaceutical Manufacturers Industry Analysis
Check our Company Profile, SWOT and Revenue Analysis!
Contact: |
|
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article